About Akshat Jain, MD, MPH

As a Board Certified Hematologist Oncologist I specilize in caring for people with blood and cancer disorders. At Loma Linda University, I am the founding director of the NASCC Sickle Cell Center of Excellence and Hemophilia Treatment Center since inception in 2019

The comprehensive care programs for blood disorders offer dedicated multidisciplinary care to deliver exceptional, patient-centered care in a COE model. 

My clinical and research focus centers on Experimental Therapeutics in cell/gene therapy & immunitherapy advancing the understanding and treatment of Hematologic disorders, with a particular emphasis on pioneering gene therapy solutions. In my roles at Loma Linda University School of Medicine and Children’s Hospital, I have spearheaded numerous clinical trials and research initiatives, helping to shape the future of hematology. My vision for the Inland Empire is to develop a lifespan inclusive Center of Excellence for hematology and gene therapy, providing cutting-edge care for rare disorders.

Over the past ten years, I have successfully developed and expanded specialized clinical verticals, and over the last five years, I have built a thriving research enterprise with over 130 research projects and clinical trials that have led to several national and international publications , book chapters and drug development that have received regulatory approvals in North America.

As the Designed site for American Society of Hematology & serving as Ambassador I have developed a dedicated educational cirriculum and clincial skills program for medical and nusrsing students at the LLU school of Medicine.

Looking ahead, I am committed to creating parallel services and new programs that support women’s health in rare diseases and improve access to hematologic care for underserved populations worldwide.

Recognized as a key opinion leader in pediatric bleeding disorders and sickle cell disease, my work and insights are frequently featured in national and international media. I am especially known for our team’s research on immunotherapy, endothelial dysfunction in sickle cell disease, COVID-related coagulopathy, and global health disparities in access to care. Our research also addresses women’s health and fertility in sickle cell disease, as well as barriers to optimal care across more than 17 countries.

I am honored to have received numerous awards for my contributions to pediatric healthcare, and to have served in leadership roles within national and international medical organizations. Recent recognitions include Induction into the most prestigious Research sorority Sigma Xi in 2026 , Provider of the Year Award by the Hemophilia Foundation 2025, Healing Hands Honoree by Loma Linda Health , and Ambassador for the American Society of Hematology.